Patrick A. Sturgeon

Patrick Sturgeon is a Managing Partner at Brookline Capital Markets, a division of Arcadia Securities, LLC, a Healthcare focused investment bank which provides capital raising, M&A, and strategic advisory services. He has completed a diverse series of transactions to include Initial Public Offerings, PIPEs, Follow-Ons, Private Placements from Series A through Private-to-Public Crossovers, Asset Back Lending, Buy & Sell-Side Merger Advisory, Secondary Trading and Strategic Advisory Services. He is asked to speak at events on topics to include the equity capital markets, the healthcare industry and transaction execution.
He has been the Chief Financial Officer of three biotech focused SPACs that have successfully closed acquisitions – Alpha Healthcare Acquisition Corp. (Humacyte (NASDAQ: HUMA) – first company to have RMAT designation), Alpha Healthcare Acquisition Corp. III (Carmell Corp. – Platelet-rich plasma (PRP) therapeutic focused on wound healing) and Brookline Capital Acquisition Corp I (Apexigen – Oncology focused). He continues to serve as Vice Chairman to the public company Longevity Health Holdings (NASDAQ: XAGE).
As a Founding Partner of Covenant Venture Capital, Mr. Sturgeon has led investments in prominent companies like Anduril, Anthropic, EpiBone, Dataminr, SpaceX and others, demonstrating his strategic investment acumen across high growth sectors such as artificial intelligence, biotech, data analytics and defense. He led the process to have Covenant confirmed as a Qualified Venture Fund for NJEDA which allows them to receive matching investment funds from the State of New Jersey.
He also serves on the Advisory Board of the private company ZeroToOne.AI, a tailored AI marketing solution for Fortune 500 companies.
Previously, he was a Managing Director at Axiom Capital Management, a boutique investment bank and a Vice President at Freeman & Co., a Financial Services focused merger & acquisitions investment bank.
Mr. Sturgeon graduated from the University of Massachusetts at Amherst with a B.S. in Economics and from NYU Stern School of Business with a M.B.A.